Hyperhomocysteinemia and inflammatory bowel disease: Prevalence and predictors in a cross-sectional study

American Journal of Gastroenterology

Volumn 96, Issue 7, 2001, Pages 2143-2149

  Romagnuolo, Joseph ^b   Fedorak, Richard N ^a   Dias, Valerian C ^b   Bamforth, Fiona ^b   Teltscher, Marty ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE;

ADULT; AGED; AMINO ACID DEFICIENCY; ARTICLE; DEMETHYLATION; DISEASE DURATION; ENTERITIS; FEMALE; GENETIC DISORDER; HUMAN; HYPERHOMOCYSTEINEMIA; IMMUNOMODULATION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PREVALENCE; PRIORITY JOURNAL; VITAMIN DEFICIENCY;

ADULT; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; INFLAMMATORY BOWEL DISEASES; MALE; MODELS, CHEMICAL; PREVALENCE; RISK FACTORS; VITAMIN B 12;

EID: 0034933207     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(01)02513-8     Document Type: Article

References (60)

1. Homocysteine and atherothrombosis
2. Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis
3. Homocysteine and vascular disease
4. Plasma homocysteine, a risk factor for vascular disease: Plasma levels in health, disease, and drug therapy
5. Plasma homocysteine as a risk factor for vascular disease: The European Concerted Action Project
6. Plasma homocysteine levels and mortality in patients with coronary artery disease
7. Homocysteine and risk of premature coronary disease: Evidence for a common gene mutation
8. Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism
9. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis
10. Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease
11. Hyperhomocyst(e)inemia and the increased risk of venous thromboembolism: More evidence from a case-control study
12. Vitamin B6 nutrition status and cigarette smoking
13. Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease
14. Folic acid - An innocuous means to reduce plasma homocysteine
15. The oxidant stress of hyperhomocyst(e)inemia
16. The potential role of nitric oxide in chronic inflammatory bowel disorders
17. Disorders of transsulfuration
18. Platelets in inflammatory bowel disease - Pathogenetic role and therapeutic implications
19. Heparin, cell adhesion, and pathogenesis of inflammatory bowel disease
20. Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease
21. Low molecular weight heparin as adjuvant therapy in active ulcerative colitis
22. Folate and homocysteine status and hemolysis in patients treated with sulphasalazine for arthritis
23. Effect of cigarette smoking on recurrence of Crohn's disease
24. Correlation between total homocysteine and cyclosporine concentrations in cardiac transplant recipients
25. Two thrombotic complications in a patient with active ulcerative colitis
26. Severe thrombotic complications in a postpartum patient with active Crohn's disease resulting in ischemic spinal cord injury
27. 12 deficiency-induced hyperhomocysteinemia
28. Increased prevalence of methylenetetrahydrofolate reductase C677T variant in patients with inflammatory bowel disease, and its clinical implications
29. Evaluation and intermethod comparison of the Bio-Rad high-performance liquid chromatographic method for plasma total homocysteine
30. 12 metabolism
31. Disordered methionine/homocysteine metabolism in premature vascular disease: Its occurrence, cofactor therapy, and enzymology
32. Homocysteine, lipoprotein(a) and fibrinogen: Metabolic risk factors for cardiovascular complications of chronic renal disease
33. Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients
34. Serum homocysteine and methylmalonic acid in patients with rheumatoid arthritis and cobalaminopenia
35. Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: Implications for cardiovascular disease prevention
36. Abnormal homocysteine metabolism in rheumatoid arthritis
37. Homocysteine levels in patients with rheumatoid arthritis treated with low-dose methotrexate
38. Homocysteine, methylenetetrahydrofolate reductase polymorphism, antiphospholipid antibodies, and thromboembolic events in systemic lupus erythematosus: A retrospective cohort study
39. Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus
40. The factor V Leiden mutation increases the risk of venous thrombosis in patients with inflammatory bowel disease
41. Anti-cardiolipin antibodies in patients with inflammatory bowel disease
42. Thromboembolism and resistance to activated protein C in patients with inflammatory bowel disease
43. Thrombotic vascular risk factors in inflammatory bowel disease
44. Evidence for McKusick's hypothesis of deficient collagen cross-linking in patients with homocysteinuria
45. Total parenteral nutrition and complete bowel rest in the management of Crohn's disease
46. Parenteral nutrition in inflammatory bowel disease
47. Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis
48. Diet and Crohn's disease: Characteristics of the pre-illness diet
49. Diet counselling improves the clinical course of patients with Crohn's disease
50. Remission induction in refractory Crohn's disease using a high calorie whole diet
51. A randomized study of instructional variations in nutrition counseling and their efficacy in the treatment of hyperlipidemia
52. Prospectively measured red cell folate levels in methotrexate treated patients with rheumatoid arthritis: Relation to withdrawal and side effects
53. Transdermal nicotine for active ulcerative colitis
54. Transdermal nicotine for mildly to moderately active ulcerative colitis. A randomized, double-blind, placebo-controlled trial
55. Nicotine therapy for ulcerative colitis: A review of rationale, mechanisms, pharmacology, and clinical results
56. Homocysteine diet and cardiovascular diseases: A statement for healthcare professionals from the Nutrition Committee, American Heart Association
57. Homocysteine: A new test whose time has come?
58. Homocysteine induces congenital defects of the heart and neural tube: Effect of folica acid
59. Prevention of neural tube defects: Results of the Medical Research Council vitamin study
60. Prevention of the first occurrence of neural-tube defects by preconceptional vitamin supplementation